Stock Markets

[B-SIDE Podcast] From lab to market: Filipino scientists merge tech innovation with business

Published

Follow us on Spotify BusinessWorld B-Side

Hemogen is a possible business spin-off that’s composed of a team of scientists from the DoST’s Philippine Nuclear Research Institute. With the institute’s radiation technology, the team was able to develop materials that can control severe bleeding in trauma patients. In this B-Side episode, two of the team members talk about Hemogen’s plans for commercializing the product.

Interview by Patricia Mirasol
Audio editing by Jayson Mariñas

Follow us on Spotify BusinessWorld B-Side

In this article:

You May Also Like

Finance

Dragons’ Den star Sara Davies retakes Crafter’s Companion reins amid pre-pack rescue

Sara Davies, the Dragons’ Den entrepreneur, is set to regain control of Crafter’s Companion, the craft supply business she founded, through a fast-tracked pre-pack...

January 10, 2025

Stock Markets

Have a taste of the perfect day in paradise with SULÀ Spirits

SULA Spirits celebrates Filipino artistry with bottles that are as refined as the craft they hold. Have you ever wondered how the perfect day...

January 8, 2025

Finance

5.4 million yet to file self-assessment tax returns, warns HMRC

Millions of people across the UK are at risk of penalties after HM Revenue & Customs (HMRC) revealed that 5.4 million taxpayers have yet...

January 6, 2025

Finance

Firms slash jobs at quickest rate in four years following budget tax hikes

Businesses shed jobs at the fastest pace in four years last month after higher employment costs and mounting uncertainty from the autumn budget dented...

January 7, 2025

Exit mobile version